Regulation of Expression of Growth Arrest-Specific Genes in Mouse Fibroblasts

Literature Cited

• Almendral, J. M., D. Sommer, H. MacDonald-Bravo, J. Burckhardt, J. Perera, and R. Bravo. 1988. Complexity of the early genetic response to growth factors in mouse fibroblasts. Mol. Cell. Biol. 8:2140–2148.
   PubMed Web of Science ®Google Scholar
• Armelin, H. A., M. C. S. Armelin, K. Kelly, T. Stewart, P. Leder, B. H. Cochran, and C. D. Stiles. 1984. Functional role for c-myc in mitogenic response to platelet-derived growth factor. Nature (London) 310:655–660.
   PubMed Web of Science ®Google Scholar
• Bedard, P.-A., Y. Yannoni, D. L. Simmons, and R. L. Erikson. 1989. Rapid repression of quiescence-specific gene expression by epidermal growth factor, insulin, and pp60v-src . Mol. Cell. Biol. 9:1371–1375.
   PubMedGoogle Scholar
• Bedard, P.-C., S. D. Balk, H. S. Gunther, A. Morisi, and R. L. Erikson. 1987. Repression of quiescence-specific polypeptides in chicken heart mesenchymal cells transformed by Rous sarcoma virus. Mol. Cell. Biol. 7:1450–1458.
   PubMedGoogle Scholar
• Bohmann, D., T. J. Bos, T. Nishimura, P. K. Vogt, and R. Tjian. 1987. Human proto-oncogene c-jun encodes a protein with antigenic and enhancer binding properties of transcription factor AP-1. Science 238:1386–1392.
   PubMed Web of Science ®Google Scholar
• Brawerman, G. 1989. mRNA decay: finding the right targets. Cell 57:9–10.
   PubMed Web of Science ®Google Scholar
• Brewer, G., and J. Ross. 1989. Regulation of c-myc mRNA stability in vitro by a labile destabilizer with an essential nucleic acid component. Mol. Cell. Biol. 9:1996–2006.
   PubMed Web of Science ®Google Scholar
• Carpenter, G. 1987. Receptors for epidermal growth factor and other polypeptide mitogens. Annu. Rev. Biochem. 56:881–914.
   PubMed Web of Science ®Google Scholar
• Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. J. Biochem. 18:5294–5299.
   Google Scholar
• Cochran, B. H., A. C. Reffel, and C. D. Stiles. 1983. Molecular cloning of gene sequences regulated by platelet-derived growth factor. Cell 33:939–947.
   PubMed Web of Science ®Google Scholar
• Cohen, D. R., and T. Curran. 1988. fra-1: a serum-inducible, cellular immediate-early gene that encodes a Fos-related antigen. Mol. Cell. Biol. 8:2063–2069.
   PubMed Web of Science ®Google Scholar
• Craig, R. W., and R. Sager. 1985. Suppression of tumorigenicity in hybrids of normal and oncogene-transformed CHEF cells. Proc. Natl. Acad. Sci. USA 82:2062–2066.
   PubMed Web of Science ®Google Scholar
• Deuel, T. F. 1987. Polypeptide growth factors: roles in normal and abnormal cell growth. Annu. Rev. Cell Biol. 3:443–492.
   PubMedGoogle Scholar
• Gewirtz, A. M., and B. Calabretta. 1988. A c-myb antisense oligodeoxynucleotide inhibits normal human hematopoeisis in vitro. Science 242:1303–1306.
   PubMed Web of Science ®Google Scholar
• Greenberg, M. E., and E. B. Ziff. 1984. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature (London) 311:433–438.
   PubMed Web of Science ®Google Scholar
• Hansen, M. F., and W. K. Cavenee. 1988. Tumor suppressors: recessive mutations that lead to cancer. Cell 53:172–173.
   Web of Science ®Google Scholar
• Heikkila, R., G. Schwab, E. Wickstrom, S. L. Loke, D. H. Pluznik, R. Watt, and L. M. Neckers. 1987. A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from GO to Gl. Nature (London) 328:445–449.
   PubMed Web of Science ®Google Scholar
• Kaczmarek, L., J. K. Hyland, R. Watt, M. Rosenberg, and R. Baserga. 1985. Microinjected c-mvc as a competence factor. Science 228:1313–1315.
   PubMed Web of Science ®Google Scholar
• Knabbe, C., M. E. Lippman, L. M. Wakefield, K. C. Flanders, A. Kasid, R. Derynck, and R. B. Dickson. 1987. Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells. Cell 48:417–428.
   PubMed Web of Science ®Google Scholar
• Kohase, M., D. Henriksen-DeStefano, L. T. May, J. Vlicek, and P. B. Sehgal. 1986. Induction of β2-interferon by tumor necrosis factor: a homeostatic mechanism in the control of cell proliferation. Cell 45:659–666.
   PubMed Web of Science ®Google Scholar
• Lin, S. L., T. Kikuchi, W. J. Pledger, and I. Tamm. 1986. Interferon inhibits the establishment of competence in Go-S-Phase transition. Science 233:356–359.
   PubMed Web of Science ®Google Scholar
• Linzer, D. I. H., and D. Nathans. 1983. Growth-related changes in specific mRNAs of cultivated mouse cells. Proc. Natl. Acad. Sci. USA 80:4271–4275.
   PubMedGoogle Scholar
• Linzer, D. I. H., and E. L. Wilder. 1987. Control of proliferin gene expression in serum-stimulated mouse cells. Mol. Cell. Biol. 7:2080–2086.
   PubMedGoogle Scholar
• Muller, R., R. Bravo, J. Burckhardt, and T. Curran. 1984. Induction of c-fos gene and protein by growth factors precedes activation of c-myc. Nature (London) 312:716–720.
   PubMed Web of Science ®Google Scholar
• Pardee, A. B., R. Dubrow, J. L. Hamlin, and R. F. Kletzien. 1978. Animal cell cycle. Annu. Rev. Biochem. 47:715–750.
   PubMed Web of Science ®Google Scholar
• Roberts, A. B., and M. B. Sporn. 1988. Transforming growth factor β. Adv. Cancer Res. 51:107–145.
   PubMed Web of Science ®Google Scholar
• Ryder, K., L. Lau, and D. Nathans. 1988. A gene activated by growth factors is related to the oncogene v-jun. Proc. Natl. Acad. Sci. USA 85:1487–1491.
   PubMed Web of Science ®Google Scholar
• Schneider, C., R. M. King, and L. Philipson. 1988. Genes specifically expressed at growth arrest of mammalian cells. Cell 54:787–793.
   PubMed Web of Science ®Google Scholar
• Sorrentino, V., and S. Bandyopadhyay. 1989. ΤGFβ inhibits GO/S-phase transition in primary fibroblasts. Loss of response to the antigrowth effect of ΤGFβ is observed after immortalization. Oncogene 4:569–574.
   PubMedGoogle Scholar
• Sorrentino, V., V. Drozdoff, M. D. McKinney, L. Zeitz, and E. Fleissner. 1986. Potentiation of growth factor activity by exogenous c-mvc expression. Proc. Natl. Acad. Sci. USA 83:8167–8171.
   PubMedGoogle Scholar
• Sorrentino, V., V. Drozdoff, L. Zeitz, and E. Fleissner. 1987. Increased radiation-induced transformation in C3H/1OT1/2 cells after transfer of an exogenous c-mvc gene. Proc. Natl. Acad. Sci. USA 84:4131–4134.
   PubMed Web of Science ®Google Scholar
• Sporn, M. B., and A. B. Roberts. 1988. Peptide growth factors are multifunctional. Nature (London) 332:217–219.
   PubMed Web of Science ®Google Scholar
• Tiwari, R. K., J. Kusari, R. Kumar, and G. C. Sen. Gene induction by interferons and double-stranded RNA: selective inhibition by 2-aminopurine. Mol. Cell. Biol. 8:4289–4292.
   Google Scholar
• Wang, E. 1986. A 57,000-mol-wt protein uniquely present in nonproliferating cells and senescent human fibroblasts. J. Cell Biol. 100:545–551.
   Google Scholar
• Wang, E. 1985. Rapid disappearance of statin, a nonproliferating and senescent cell-specific protein, upon reentering the process of cell cycling. J. Cell Biol. 101:1695–1701.
   PubMedGoogle Scholar
• Wang, E. 1987. Contact-inhibition-induced quiescent state is marked by intense nuclear expression of statin. J. Cell Physiol. 133:151–157.
   PubMed Web of Science ®Google Scholar
• Wang, E., and S. L. Lin. 1986. Disappearance of statin, a protein marker for non-proliferating and senescent cells, following serum-stimulated cell cycle entry. Exp. Cell Res. 167:135–143.
   PubMedGoogle Scholar
• Whyte, P., K. J. Bucjkovich, J. M. Horowitz, S. H. Friend, M. Raybuck, R. A. Weinberg, and E. Harlow. 1988. Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature (London) 334:124–129.
   PubMed Web of Science ®Google Scholar
• Williams, L. T. 1989. Signal transduction by the platelet-derived growth factor receptor. Science 243:1564–1570.
   PubMed Web of Science ®Google Scholar
• Zerial, M., L. Toschi, R. P. Ryseck, M. Schuermann, R. Muller, and R. Bravo. 1989. The product of a novel growth factor activated gene, fos B, interacts with JUN proteins enhancing their DNA binding activity. EMBO J. 8:805–813.
   PubMed Web of Science ®Google Scholar
• Zinn, K., A. Keller, L. A. Whitemore, and T. Maniatis. 1988. 2-Aminopurine selectively inhibits the induction of β-interferon, c-fos. and c-myc gene expression. Science 240:210–213.
   PubMed Web of Science ®Google Scholar